Growth Hormone Disorders

Delay in GH replacement therapy OK after craniopharyngioma treatment

  A delay in growth hormone replacement therapy (GHRT) after childhood-onset craniopharyngioma treatment is not associated with the risk of recurrence or tumor progression, according to a study. In this retrospective, observational, a cohort of 71 childhood-onset craniopharyngiomas treated with recombinant human growth hormone (rhGH), including 27 treated ≥12 after...